CYTK

Cytokinetics, Incorporated Press Releases

$4.6
*  
0.31
7.23%
Get CYTK Alerts
*Delayed - data as of Jul. 11, 2014  -  Find a broker to begin trading CYTK now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Cytokinetics Announced Additional Results Relating to Tirasemtiv from Pre-Specificed Subgroup Analyses of BENEFIT-ALS
7/10/2014 7:30:00 AM - GlobeNewswire

Biotech Equities under the Scanner -- Research on Alexion Pharma, InterMune, Cytokinetics, and Biogen Idec
7/7/2014 5:55:00 AM - PR Newswire

Cytokinetics Announces Additional Data from BENEFIT-ALS to be Presented at the 13th International Congress on Neuromuscular Diseases
7/3/2014 7:31:00 AM - GlobeNewswire

Cytokinetics Announces Data Relating to Tirasemtiv Presented at the 2014 Annual Spinal Muscular Atrophy Conference
6/13/2014 4:00:00 PM - GlobeNewswire

Cytokinetics Announces Two Presentations Relating to Tirasemtiv to be Presented at the 2014 Annual Spinal Muscular Atrophy Conference
6/6/2014 7:30:00 AM - GlobeNewswire

Cytokinetics Announces Further Results from BENEFIT-ALS Relating to Effects Following Withdrawal of Tirasemtiv
6/2/2014 7:30:00 AM - GlobeNewswire

Cytokinetics to Present at Upcoming Healthcare Conferences
5/28/2014 4:00:00 PM - GlobeNewswire

Cytokinetics Announces Additional Data From BENEFIT-ALS to be Presented at the Joint Congress of European Neurology
5/27/2014 7:30:00 AM - GlobeNewswire

Cytokinetics Announces Three Publications Relating to Tirasemtiv and the Impact of Skeletal Muscle Activation on Respiratory Function and Muscle Strength
5/21/2014 7:30:00 AM - GlobeNewswire

Cytokinetics to Hold Annual Meeting of Stockholders
5/15/2014 4:01:00 PM - GlobeNewswire

Cytokinetics, Incorporated Reports First Quarter 2014 Financial Results
5/6/2014 4:02:00 PM - GlobeNewswire

Biotech Stocks Scanner -- Research on PDL BioPharma, Cytokinetics, Vical, and Peregrine Pharma
5/6/2014 12:41:00 PM - PR Newswire

Cytokinetics Announces Additional Results from BENEFIT-ALS
4/29/2014 7:30:00 AM - GlobeNewswire

The ALS Association Honors Lou Gehrig's Legacy and 75th Anniversary of His Famous Farewell Speech
4/25/2014 2:23:00 PM - PR Newswire

Cytokinetics Announces Top-Line Results From BENEFIT-ALS
4/25/2014 7:30:00 AM - GlobeNewswire

Cytokinetics to Announce First Quarter Results on May 6, 2014
4/24/2014 4:39:00 PM - GlobeNewswire

Cytokinetics to Host Investor Breakfast and Webcast Following Presentation of Results from BENEFIT-ALS
4/23/2014 7:30:00 AM - GlobeNewswire

Cytokinetics Announces Results From BENEFIT-ALS Will Be Presented at the 66th Annual Meeting of the American Academy of Neurology
4/22/2014 7:30:00 AM - GlobeNewswire